Astrazeneca Up Over 9% After 4Q Revenue, Core EPS Beats -- Data Talk
14 Febrero 2019 - 1:59PM
Noticias Dow Jones
Astrazeneca PLC Sponsored ADR (AZN) is currently at $39.96, up
$3.38 or 9.24%
-- Would be highest close since Nov. 29, 2018, when it closed at
$40.21
-- On pace for largest percent increase since April 28, 2014,
when it rose 12.16%
-- Earlier Thursday, Astrazeneca said fourth-quarter revenue
rose 11% to $6.42 billion, ahead of analysts' expectations of $6.32
billion, based on a FactSet consensus forecast and core earnings
per share increased 22% to $1.58 in the fourth quarter. This beat
analysts' expectations of $1.48
-- Currently up four of the past six days
-- Up 9.24% month-to-date
-- Up 5.21% year-to-date
-- Up 17.46% from 52 weeks ago (Feb. 15, 2018), when it closed
at $34.02
-- All data as of 2:21:06 PM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 14, 2019 14:44 ET (19:44 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024